Literature DB >> 31521791

Quantitative evaluation of bone-resorptive lesion volume in osteonecrosis of the femoral head using micro-computed tomography.

Shoji Baba1, Goro Motomura2, Satoshi Ikemura1, Yusuke Kubo1, Takeshi Utsunomiya1, Hiroyuki Hatanaka1, Koichiro Kawano1, Yasuharu Nakashima1.   

Abstract

Objectives To quantify the volume of bone-resorptive lesions in post-collapse osteonecrosis of the femoral head (ONFH) using micro-computed tomography (micro-CT) and assess their characteristics in post-collapse ONFH. Methods We investigated 35 femoral heads resected from 35 patients with ONFH (20 men and 15 women; mean age, 47.2 years). On each of seven coronal high-resolution micro-CT slices of the femoral head, the bone-resorptive areas were extracted using bone microstructure measurement software. Next, the total bone-resorptive volume ratio, defined as the ratio of all bone-resorptive cross-sectional areas to all femoral head cross-sectional areas in all seven slices, was calculated. Associations between total bone-resorptive volume ratio and sex, age, ONFH-associated factors, patient workload levels, ONFH stage, ONFH type, necrotic volume on magnetic resonance imaging, and duration from the onset of pain to surgery were analyzed. Lesion location and the association between bone-resorptive lesion and collapse were also evaluated. Results The mean total bone-resorptive volume ratio was 7.0±6.0%, which varied significantly by ONFH stage (ARCO collapse quantitation 3A, 3.5±2.1%; 3B, 6.8±3.0%; and 3C, 13.6±8.8%). ONFH stage was independently associated with total bone-resorptive volume ratio (P<0.05). Furthermore, high bone-resorptive volume ratios were found in the anterior femoral head and were associated with collapse. Conclusions This study demonstrated that bone-resorptive volume in post-collapse ONFH was significantly associated with the disease stage, which was more widespread in the anterior portion of the femoral head than in the posterior portion.
Copyright © 2019 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bone resorption; Collapse; Micro-CT; Osteonecrosis of the femoral head

Mesh:

Year:  2019        PMID: 31521791     DOI: 10.1016/j.jbspin.2019.09.004

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

1.  Collapse-Related Bone Changes in Osteonecrotic Femoral Heads at Multidetector CT: Comparison between Femoral Heads with Limited and Advanced Collapse.

Authors:  Charbel Mourad; Souad Acid; Nicolas Michoux; Anthony Awad; Bruno Vande Berg
Journal:  J Belg Soc Radiol       Date:  2022-06-09       Impact factor: 1.912

2.  Prediction of the progression of femoral head collapse in ARCO stage 2-3A osteonecrosis based on the initial bone resorption lesion.

Authors:  Shan Shi; Ping Luo; Li Sun; Limin Xie; Tong Yu; Zhenchang Wang; Xuedong Yang
Journal:  Br J Radiol       Date:  2020-11-12       Impact factor: 3.039

Review 3.  The Role of Structural Deterioration and Biomechanical Changes of the Necrotic Lesion in Collapse Mechanism of Osteonecrosis of the Femoral Head.

Authors:  Peng Wang; Cheng Wang; Haoye Meng; Guangbo Liu; Huo Li; Jianming Gao; Hua Tian; Jiang Peng
Journal:  Orthop Surg       Date:  2022-04-21       Impact factor: 2.279

4.  Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study.

Authors:  Zhaoming Zhang; Tianye Lin; Yuan Zhong; Wenting Song; Peng Yang; Ding Wang; Fan Yang; Qingwen Zhang; Qiushi Wei; Wei He
Journal:  Open Med (Wars)       Date:  2022-07-13

5.  An injectable self-adaptive polymer as a drug carrier for the treatment of nontraumatic early-stage osteonecrosis of the femoral head.

Authors:  Ning Kong; Hang Yang; Run Tian; Guanzhi Liu; Yiyang Li; Huanshuai Guan; Qilu Wei; Xueshan Du; Yutian Lei; Zhe Li; Ruomu Cao; Yiwei Zhao; Xiaohui Wang; Kunzheng Wang; Pei Yang
Journal:  Bone Res       Date:  2022-03-12       Impact factor: 13.567

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.